{"id":"NCT03378635","sponsor":"Zealand Pharma","briefTitle":"A Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Type 1 Diabetes Subjects","officialTitle":"A Phase 3, Randomized, Double-blind, Parallel Trial to Confirm the Clinical Efficacy and Safety of Dasiglucagon in Rescue Treatment of Hypoglycemia in Subjects With Type 1 Diabetes Mellitus Compared to Placebo and With Reference to GlucaGen","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-12-07","primaryCompletion":"2018-04-27","completion":"2018-05-25","firstPosted":"2017-12-20","resultsPosted":"2021-05-10","lastUpdate":"2021-06-10"},"enrollment":170,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Hypoglycemia","Diabetes Mellitus, Type 1"],"interventions":[{"type":"DRUG","name":"Dasiglucagon","otherNames":["ZP4207"]},{"type":"DRUG","name":"GlucaGen","otherNames":["GlucaGen HypoKit"]},{"type":"DRUG","name":"Placebo","otherNames":["Placebo for dasiglucagon"]}],"arms":[{"label":"Dasiglucagon","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"GlucaGen®","type":"ACTIVE_COMPARATOR"}],"summary":"The objective of the trial is to demonstrate superiority of dasiglucagon compared to placebo following a single subcutaneous dose administered to subjects with type 1 diabetes mellitus (T1DM) with insulin-induced hypoglycemia. Additionally to compare the glycemic response observed after administration dasiglucagon with that of GlucaGen®.","primaryOutcome":{"measure":"Time to Plasma Glucose Recovery","timeFrame":"0-45 minutes after dosing","effectByArm":[{"arm":"Dasiglucagon 0.6 mg","deltaMin":10,"sd":null},{"arm":"Placebo","deltaMin":40,"sd":null},{"arm":"GlucaGen® 1.0 mg","deltaMin":12,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":13},"locations":{"siteCount":5,"countries":["United States","Austria","Canada","Germany"]},"refs":{"pmids":["35239971"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":82},"commonTop":["Nausea","Hypoglycemia","Vomiting","Headache","Nasopharyngitis"]}}